Upgrade to SI Premium - Free Trial

Leerink Partners Downgrades AstraZeneca (AZN) to Market Perform

July 27, 2017 9:53 AM
Leerink Partners downgraded AstraZeneca (NYSE: AZN) from Outperform to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles